Santa Ana Bio
Alameda, CA · Biotechnology · 50 employees
Santa Ana Bio is a Bay Area biotech focused on leveraging it’s multiomics and protein engineering platforms to design precision biologics for the treatment of patients with serious immune related diseases.
Funding history
- Funding Round — $20.0M — Jun 2024
- Series series b — $168.0M — Jun 2024
- Funding Round — $35.3M — Feb 2023
- Funding Round — $8.0M — Jun 2021
Recent signals
- Jun 17, 2024: Raised $20.0M
- Jun 14, 2024: Raised $168.0M in Series series b
- Feb 28, 2023: Raised $35.3M
- Jun 01, 2021: Raised $8.0M
See plans & pricing → Track Santa Ana Bio’s funding, hiring, and signals — with verified contacts — on Fundz.